Lobbying

Tiber Creek Group on Behalf of Organon's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q2 2025; the issues it reports most are Pharmacy and Medicare/Medicaid.

Tiber Creek Group on Behalf of Organon

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$90K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q2 2025
The first quarter a report named it

Lobbying by quarter

Tiber Creek Group on Behalf of Organon lobbying by quarter
Tiber Creek Group on Behalf of Organon lobbying by quarter
QuarterAmountReports
Q2 2025$30K1
Q3 2025$30K1
Q4 2025$30K1
Q1 2026$30K1
Q2 2026$30K1
Q3 2026$00

By issue

  • Pharmacy$100K · 4 reports
  • Medicare and Medicaid$40K · 2 reports
  • Health issues$10K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • SENATE5 reports

Firms it paid

Firm
B Hall Strategies$150K5 quarters

Former officials lobbying for it

Former position
JAMES BRYANT HALL iiStaff Director, Senate Veterans Affairs Committee; Legislative Director, Senator Bob GrahamQ2 2026

Lobbying reports

Filed by
07/19for Q2B Hall Strategies$30K
04/09for Q1B Hall Strategies$30K
01/19for Q4 2025B Hall Strategies$30K
25/10/20for Q3 2025B Hall Strategies$30K
25/07/21for Q2 2025B Hall Strategies$30K
25/07/15for Q2 2025B Hall StrategiesUnder $5,000